References
- Chen JK, Ghasri P, Aguilar G, van Drooge AM, Wolkerstorfer A, Kelly KM, Heger M. An overview of clinical and experimental treatment modalities for port wine stains. J Am Acad Dermatol. 2012;67(2):289–304. doi:https://doi.org/10.1016/j.jaad.2011.11.938.
- Phung TL, Oble DA, Jia W, Benjamin LE, Mihm MC Jr., Nelson JS. Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks. Lasers Surg Med. 2008;40(1):1–5. doi:https://doi.org/10.1002/lsm.20599.
- Jia W, Sun V, Tran N, Choi B, Liu SW, Mihm MC Jr., Phung TL, Nelson JS. Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med. 2010;42(2):105–12. doi:https://doi.org/10.1002/lsm.20890.
- Tan W, Jia W, Sun V, Mihm MC Jr., Nelson JS. Topical rapamycin suppresses the angiogenesis pathways induced by pulsed dye laser: molecular mechanisms of inhibition of regeneration and revascularization of photocoagulated cutaneous blood vessels. Lasers Surg Med. 2012;44(10):796–804. doi:https://doi.org/10.1002/lsm.22101.
- Chang HS, Kim YG, Lee JH. Treatment using a long pulsed nd:yag laser with a pulsed dye laser for four cases of blebbed port wine stains. Ann Dermatol. 2011;23 Suppl 1(Suppl 1):S75–8. doi:https://doi.org/10.5021/ad.2011.23.S1.S75.
- Zutt M. Laser treatment of vascular dermatological diseases using a pulsed dye laser (595 nm) in combination with a Neodym:YAG-laser (1064 nm). Photochem Photobiol Sci. 2019;18(7):1660–68. doi:https://doi.org/10.1039/C9PP00079H.
- Alster TS, Tanzi EL. Combined 595-nm and 1,064-nm laser irradiation of recalcitrant and hypertrophic port-wine stains in children and adults. Dermatol Surg. 2009;35(6):914–8; discussion 8–9. doi:https://doi.org/10.1111/j.1524-4725.2009.01155.x.
- Perruchoud DL, Cazzaniga S, Heidemeyer K, Weber B, Dietrich N, Borradori L, Adatto MA. Treatment of sporadic port-wine stains: a retrospective review of 17 cases consecutively treated by pulsed sequential dual wavelength 595 and 1064 nm laser. J Eur Acad Dermatol Venereol. 2017;31(3):557–63. doi:https://doi.org/10.1111/jdv.13975.
- Wang T, Chen D, Yang J, Ma G, Yu W, Lin X. Safety and efficacy of dual- wavelength laser (1064 + 595 nm) for treatment of non-treated port-wine stains. J Eur Acad Dermatol Venereol. 2018;32(2):260–64. doi:https://doi.org/10.1111/jdv.14490.
- Radmanesh M, Radmanesh R. Successful treatment of isolated venous malformation with 1444-nm fiberoptic Nd-YAG laser. J Cosmet Laser Ther. 2016;18(2):91–94. doi:https://doi.org/10.3109/14764172.2015.1114636.
- Radmanesh M, Radmanesh R. Combined pulsed dye laser and fiberoptic Nd-YAG laser for the treatment of hypertrophic port wine stain. J Cosmet Laser Ther. 2017;19(6):334–36. doi:https://doi.org/10.1080/14764172.2017.1314508.
- Kelly KM, Kimel S, Smith T, Stacy A, Hammer-Wilson MJ, Svaasand LO, Nelson JS. Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Lasers Surg Med. 2004;34(5):407–13. doi:https://doi.org/10.1002/lsm.20041.
- Smith TK, Choi B, Ramirez-San-Juan JC, Nelson JS, Osann K, Kelly KM. Microvascular blood flow dynamics associated with photodynamic therapy, pulsed dye laser irradiation and combined regimens. Lasers Surg Med. 2006;38(5):532–39. doi:https://doi.org/10.1002/lsm.20335.
- Channual J, Choi B, Osann K, Pattanachinda D, Lotfi J, Kelly KM. Vascular effects of photodynamic and pulsed dye laser therapy protocols. Lasers Surg Med. 2008;40(9):644–50. doi:https://doi.org/10.1002/lsm.20673.
- Tournas JA, Lai J, Truitt A, Huang YC, Osann KE, Choi B, Kelly KM. Combined benzoporphyrin derivative monoacid ring photodynamic therapy and pulsed dye laser for port wine stain birthmarks. Photodiagnosis Photodyn Ther. 2009;6(3–4):195–99. doi:https://doi.org/10.1016/j.pdpdt.2009.10.002.
- Ohshiro T, Nakajima T, Ogata H, Kishi K. Histological responses of cutaneousvascular lesions following photodynamic therapy with talaporfin sodium: a chicken comb model. Keio J Med. 2009;58(3):176–84. doi:https://doi.org/10.2302/kjm.58.176.
- Bromley E, Briggs B, Keltner L, Wang SS. Characterization of cutaneous photosensitivity in healthy volunteers receiving talaporfin sodium. Photodermatol Photoimmunol Photomed. 2011;27(2):85–89. doi:https://doi.org/10.1111/j.1600-0781.2011.00573.x.
- Kelly KM, Moy WJ, Moy AJ, Lertsakdadet BS, Moy JJ, Nguyen E, Nguyen A, Osann KE, Choi B. Talaporfin sodium-mediated photodynamic therapy alone and in combination with pulsed dye laser on cutaneous vasculature. J Invest Dermatol. 2015;135(1):302–04. doi:https://doi.org/10.1038/jid.2014.304.
- Liu S, Yang C, Yang S, Wang Z, Luo D, Zhang X. Topical application of 5-aminolevulinic acid followed by 595-nm pulsed dye laser irradiation for the treatment of recalcitrant port-wine stains: a primary study. J Cosmet Laser Ther. 2012;14(4):189–92. doi:https://doi.org/10.3109/14764172.2012.699677.
- Zeng M, Shen S, Chen W, Yang C, Liu S. Superficial hemangioma is better treated by topical 5-aminolevulinic followed by 595-nm pulsed dye laser therapy rather than 595-nm laser therapy alone. Lasers Med Sci. 2017;32(8):1889–93. doi:https://doi.org/10.1007/s10103-017-2304-9.
- Bae YC, Alabdulrazzaq H, Brauer JA, Geronemus RG. Treatment of recalcitrant port-wine stains (PWS) using a combined pulsed dye laser (PDL) and radiofrequency (RF) energy device. J Am Acad Dermatol. 2017;76(2):321–26. doi:https://doi.org/10.1016/j.jaad.2016.03.004.
- Chiang GG, Abraham RT. Targeting the mTOR signaling network in cancer. Trends Mol Med. 2007;13(10):433–42. doi:https://doi.org/10.1016/j.molmed.2007.08.001.
- Brugarolas JB, Vazquez F, Reddy A, Sellers WR, Kaelin WG Jr. TSC2 regulates VEGF through mTOR-dependent and –independent pathways. Cancer Cell. 2003;4(2):147–58. doi:https://doi.org/10.1016/S1535-6108(03)00187-9.
- Leducq S, Giraudeau B, Tavernier E, Maruani A. Topical use of mammalian target of rapamycin inhibitors in dermatology: a systematic review with meta-analysis. J Am Acad Dermatol. 2019;80(3):735–42. doi:https://doi.org/10.1016/j.jaad.2018.10.070.
- Herry I, Neukirch C, Debray MP, Mignon F, Crestani B. Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex. Eur J Intern Med. 2007;18(1):76–77. doi:https://doi.org/10.1016/j.ejim.2006.07.017.
- Gao L, Phan S, Nadora DM, Chernova M, Sun V, Preciado SM, Ballew B, Jia Z, Jia W, Wang G, et al. Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways. Lasers Surg Med. 2014;46(9):679–88. doi:https://doi.org/10.1002/lsm.22296.
- Nelson JS, Jia W, Phung TL, Mihm MC Jr. Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration. Lasers Surg Med. 2011;43(10):939–42. doi:https://doi.org/10.1002/lsm.21141.
- Griffin TD Jr., Foshee JP, Finney R, Saedi N. Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment. Lasers Surg Med. 2016;48(2):193–96. doi:https://doi.org/10.1002/lsm.22436.
- Marqués L, Núñez-Córdoba JM, Aguado L, Pretel M, Boixeda P, Nagore E, Baselga E, Redondo P. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial. J Am Acad Dermatol. 2015;72(1):151–8.e1. doi:https://doi.org/10.1016/j.jaad.2014.10.011.
- Doh EJ, Ohn J, Kim MJ, Kim YG, Cho S. Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation. J Dermatolog Treat. 2017;28(7):672–77. doi:https://doi.org/10.1080/09546634.2017.1306018.
- Greveling K, Prens EP, van Doorn MB. Treatment of port wine stains using pulsed dye laser, erbium YAG laser, and topical rapamycin (sirolimus)-a randomized controlled trial. Lasers Surg Med. 2017;49(1):104–09. doi:https://doi.org/10.1002/lsm.22548.
- Artzi O, Mehrabi JN, Heyman L, Friedman O, Mashiah J. Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application. Dermatol Ther. 2020;33(1):e13172. doi:https://doi.org/10.1111/dth.13172.
- Wagstaff AJ, Perry CM. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs. 2007;67(15):2187–210. doi:https://doi.org/10.2165/00003495-200767150-00006.
- Sidbury R, Neuschler N, Neuschler E, Sun P, Wang XQ, Puscasiu E, Gugneja S, Miller R, Tomai M, Paller AS, et al. Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol. 2003;121(5):1205–09. doi:https://doi.org/10.1046/j.1523-1747.2003.12521.x.
- Ho NT, Lansang P, Pope E. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol. 2007;56(1):63–68. doi:https://doi.org/10.1016/j.jaad.2006.06.011.
- Bongiorno MR, Aricò M. Preliminary communication: imiquimod in mixed capillary/lymphatic malformation. Dermatol Ther. 2008;21 Suppl 2:S39–42. doi:https://doi.org/10.1111/j.1529-8019.2008.00232.x.
- Kouba DJ, Yip D, Fincher EF, Moy RL. Topical imiquimod in the treatment of a long-standing capillary malformation. Br J Dermatol. 2007;157(5):1071–72. doi:https://doi.org/10.1111/j.1365-2133.2007.08181.x.
- Chang CJ, Hsiao YC, Mihm MC Jr., Nelson JS. Pilot study examining the combined use of pulsed dye laser and topical Imiquimod versus laser alone for treatment of port wine stain birthmarks. Lasers Surg Med. 2008;40(9):605–10. doi:https://doi.org/10.1002/lsm.20716.
- Tremaine AM, Armstrong J, Huang YC, Elkeeb L, Ortiz A, Harris R, Choi B, Kelly KM. Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod. J Am Acad Dermatol. 2012;66(4):634–41. doi:https://doi.org/10.1016/j.jaad.2011.11.958.
- Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85–94. doi:https://doi.org/10.1016/S0140-6736(16)00645-0.
- Ricci B, Ricci F, Maggiano N. Oxygen-induced retinopathy in the newborn rat: morphological and immunohistological findings in animals treated with topical timolol maleate. Ophthalmologica. 2000;214(2):136–39. doi:https://doi.org/10.1159/000027483.
- Khan M, Boyce A, Prieto-Merino D, Svensson Å, Wedgeworth E, Flohr C. The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis. Acta Derm Venereol. 2017;97(10):1167–71. doi:https://doi.org/10.2340/00015555-2681.
- Laquer VT, Hevezi PA, Albrecht H, Chen TS, Zlotnik A, Kelly KM. Microarray analysis of port wine stains before and after pulsed dye laser treatment. Lasers Surg Med. 2013;45(2):67–75. doi:https://doi.org/10.1002/lsm.22087.
- Passeron T, Maza A, Fontas E, Toubel G, Vabres P, Livideanu C, Mazer JM, Rossi B, Boukari F, Harmelin Y, et al. Treatment of port wine stains with pulsed dye laser and topical timolol: a multicenter randomized controlled trial. Br J Dermatol. 2014;170(6):1350–53. doi:https://doi.org/10.1111/bjd.12772.
- Hu-Lowe DD, Zou HY, Grazzini ML, Hallin ME, Wickman GR, Amundson K. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases et al. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3. Clin Cancer Res. 2008;14(22):7272–83. doi:https://doi.org/10.1158/1078-0432.CCR-08-0652.
- Gao L, Nadora DM, Phan S, Chernova M, Sun V, Preciado SM, Jia W, Wang G, Mihm MC Jr, Nelson JS, et al. Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser. Br J Dermatol. 2015;172(3):669–76. doi:https://doi.org/10.1111/bjd.13439.
- Cruz A, Parnot C, Ribatti D, Corvol P, Gasc JM. Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J Vasc Res. 2001;38(6):536–45. doi:https://doi.org/10.1159/000051089.
- Taquin H, Lacour JP, Le Duff F, Chiaverini C, Passeron T. Treatment of resistant port-wine stains with bosentan and pulsed dye laser: a pilot prospective study. J Eur Acad Dermatol Venereol. 2016;30(8):1432–34. doi:https://doi.org/10.1111/jdv.13275.
- Rikihisa N, Watanabe S, Satoh K, Saito Y, Sakai H. Photosensitizer effects of artificial red cells on dye laser irradiation in an animal model assuming port-wine stain treatment. Plast Reconstr Surg. 2017;139(3):707e–16e. doi:https://doi.org/10.1097/PRS.0000000000003082.
- Rikihisa N, Tominaga M, Watanabe S, Mitsukawa N, Saito Y, Sakai H. Intravenous injection of artificial red cells and subsequent dye laser irradiation causes deep vessel impairment in an animal model of port-wine stain. Lasers Med Sci. 2018;33(6):1287–93. doi:https://doi.org/10.1007/s10103-018-2480-2.
- Kelly A, Pai A, Lertsakdadet B, Choi B, Kelly KM. Microvascular effects of pulsed dye laser in combination with oxymetazoline. Lasers Surg Med. 2020;52(1):17–22. doi:https://doi.org/10.1002/lsm.23186.
- Sodha P, Suggs A, Munavalli GS, Friedman PM. A randomized controlled pilot study: combined 595-nm pulsed dye laser treatment and oxymetazoline hydrochloride topical cream superior to oxymetazoline hydrochloride cream for erythematotelangiectatic rosacea. Lasers Surg Med. 2021;53(10):1307–15. doi: https://doi.org/10.1002/lsm.23439.